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Abstract	  
	  
Introduction:	  In	  Tanzania	  and	  most	  Sub-­‐Saharan	  countries	  of	  Africa,	  the	  HIV	  infection	  remains	  an	  important	  cause	  of	  child	  mortality.	  A	  good	  opportunity	  to	  test	  children	  for	  HIV	  is	  when	  they	  attend	   health	   facilities	   for	   a	   fever	   episode.	   As	   HIV	   rapid	   tests	   are	   not	   always	   available	   in	  resource-­‐limited	  countries,	  the	  use	  of	  a	  clinical	  algorithm	  could	  provide	  guidance	  to	  clinicians	  on	  which	  febrile	  children	  should	  be	  tested	  in	  priority	  during	  these	  consultations.	  The	  criteria	  used	  in	   the	   actual	   IMCI	   algorithm	   may	   not	   necessary	   be	   the	   best	   predictors	   of	   HIV	   infection	   in	  children	  as	  little	  is	  known	  on	  the	  subject.	  The	  aim	  of	  the	  present	  study	  was	  to	  identify	  the	  clinical	  and	  laboratory	  predictors	  of	  HIV	  in	  febrile	  children	  attending	  outpatient	  clinics	  in	  Tanzania	  and	  to	   calculate	   their	   diagnostic	   performance,	   as	   well	   as	   to	   assess	   the	   performance	   of	   the	   IMCI	  criteria	  and	  algorithm	  used	  in	  Tanzania	  at	  the	  time	  of	  this	  study	  and	  determine	  if	  a	  combination	  of	  new	  predictors	  could	  have	  better	  diagnostic	  performance.	  
	  
Methods:	  A	  nested	   case-­‐control	   analysis	   in	   a	  prospective	  observational	   study	  on	  etiologies	  of	  fever	  in	  children	  aged	  less	  than	  10	  years	  attending	  health	  facilities	  in	  rural	  and	  urban	  Tanzania	  was	  performed.	  Detailed	  history	  taking,	  clinical	  examination,	  laboratory	  investigations	  and	  final	  diagnoses	  (based	  on	  pre-­‐defined	  criteria)	  were	  obtained.	  The	  sensitivity,	  specificity,	  positive	  and	  negative	   likelihood	   ratios	   were	   calculated	   in	   bivariate	   analysis	   for	   all	   significant	   predictors.	  Stepwise	  backward	  logistic	  regression	  models	  were	  used	  to	   identify	   independent	  predictors	  of	  HIV	   infection	   and	   calculate	   their	   adjusted	  Odds	  Ratios.	  New	  algorithms	  using	   the	   best	   clinical	  predictors	  found	  in	  the	  analyses	  were	  generated	  and	  compared	  with	  the	  IMCI	  HIV	  branch.	  
	  
Results:	  Of	  1004	   consecutive	   febrile	   children	   (median	   age	  18	  months),	   16	  were	  HIV	  positive.	  Regarding	   history	   taking:	   difficulty	   to	   breath	   (LR+	   6.9),	   chronic	   condition	   (LR+	   4.7),	   recent	  travel	   history	   (LR+	   4.1),	   sick	   contact	   person	   (LR+	   2.8)	   were	   found	   to	   be	   independently	  predictive	   of	   HIV.	   Regarding	   clinical	   signs:	   lymphadenopathy	   at	   any	   site	   (LR+	   10.8),	   chest	  indrawing	  (LR+	  10.7),	  hepatomegaly	  (LR+	  9.5),	  abdominal	  tenderness	  (LR+	  6.2),	  low	  weight	  for	  age	   (LR+	  4.0)	   and	   fast	  breathing	   (LR+	  3.5)	  were	   also	  predictive.	   	   Laboratory	  predictors	  were:	  hemoglobin	  <8	  mg/dl	  (LR+	  2.8),	  naso-­‐pharygeal	  pneumococcus	  load	  ≥107	  cfu/ml	  (LR+	  2.2)	  and	  naso-­‐pharygeal	  Staphylococcus	  aureus	   carriage	   (LR+	  2.0).	  Children	  with	  HIV	  were	   significantly	  more	  at	  risk	  to	  have	  a	  severe	  illness	  of	  any	  type	  (LR+	  2.9),	  and	  a	  diagnosis	  of	  radiological	  end-­‐point	   pneumonia	   (LR+	   14.8),	   acute	   otitis	   media	   (LR+	   5.6),	   or	   bronchiolitis	   (LR+	   3.7).	   On	   the	  contrary,	   the	   diagnosis	   of	   upper	   respiratory	   infection	   negatively	   predicted	   the	   HIV	   infection	  (LR+	  0.3).	  The	  HIV	  branch	  of	  the	  IMCI	  algorithm	  had	  a	  sensitivity	  of	  93.8%	  and	  a	  specificity	  of	  73.7%	  when	  using	  1	  criteria	  as	  cut	  off	   for	   testing,	  and	  a	  sensitivity	  of	  56.3%	  and	  specificity	  of	  97.2%	  when	  using	  2.	  A	  new	  algorithm	  using	  lymphadenopathy	  at	  any	  site,	  radiological	  end-­‐point	  pneumonia,	  chronic	  condition,	  abdominal	  tenderness,	  difficulty	  to	  breath,	  acute	  otitis	  media	  and	  oral	  thrush	  as	  criteria	  showed	  a	  sensitivity	  of	  93.8%,	  and	  a	  specificity	  of	  81.4%	  when	  using	  one	  criterion	  as	  cut-­‐off..	  
	  
Conclusion:	  Several	  clinical	  and	  laboratory	  predictors	  for	  HIV	  were	  found	  in	  febrile	  outpatient	  children,	  some	  of	  which	  are	  not	  included	  in	  the	  present	  IMCI	  criteria.	  These	  findings	  could	  serve	  to	   improve	   the	   actual	   IMCI	   algorithm	   and	   potentially	   increase	   the	   number	   of	   HIV	   positive	  children	  detected	  during	  consultations	  for	  acute	  care.	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1.	  Introduction	  As	  most	  Sub-­‐Saharan	  countries	  of	  Africa,	  Tanzania	  is	  severely	  affected	  by	  the	  human	  immunodeficiency	  virus	  (HIV)	  infection	  and	  around	  1.5	  million	  people	  of	  all	  ages	  were	  living	  with	  HIV	   in	  Tanzania	   in	  2012	  (1).	  HIV	   infection	  and	  acquired	   immunodeficiency	  syndrome	  (AIDS)	  were	  responsible	  for	  78’000	  deaths	  in	  Tanzania	  in	  2012	  and	  continue	  to	  be	  a	  major	  cause	  of	  infant	  mortality	  in	  Africa	  (2).	  If	  overall	  the	  commonest	  route	  of	  transmission	  remains	  the	  sexual	  one,	  a	  significant	  number	   of	   children	   are	   vertically	   infected	   around	   the	   world.	   Those	   vertical	  transmissions	   are	   estimated	   to	   be	   responsible	   of	   18%	   of	   new	   infections	   in	   Tanzania,	  representing	   the	   second	   most	   common	   way	   of	   transmission	   with	   about	   250’000	  children	   aged	   less	   than	   15	   living	   with	   HIV	   in	   that	   country	   (3),	   (4).	   Global	   use	   of	  antiretroviral	   drug	   has	   started	   since	   1996	   and	   all	   pregnant	   or	   breastfeeding	   women	  infected	   with	   HIV	   should	   nowadays	   receive	   antiretroviral	   therapy	   (ART)	   in	   order	   to	  reduce	  risks	  of	  mother-­‐to-­‐child-­‐transmission	  (MTCT).	  	  However,	  the	  estimated	  coverage	  of	  ART	  for	  prevention	  of	  MTCT	  was	  only	  73%	  in	  2013	  (5).	  Children	  generally	  acquire	  the	  virus	  from	  their	  mother	  during	  pregnancy,	  delivery	  or	  after	   their	   birth	   by	   breastfeeding.	  Usually	   they	   do	   not	   present	   any	   clinical	   features	   of	  HIV/AIDS	   soon	   after	   birth	   but	   develop	   them	   during	   infancy,	   except	   slow	   progressors	  who	  often	  only	  develop	  signs	  or	  symptoms	  in	  late	  childhood.	  Unlike	  in	  adults,	  the	  clinical	  presentation	  of	  HIV/AIDS	  can	  be	  hard	  to	  distinguish	  from	  common	  childhood	  illnesses	  as	   symptoms	   often	   overlap.	   Because	   paediatric	   HIV	   infection	   causes	   an	   important	  number	   of	   deaths	   and	   because	   some	   of	   them	   could	   be	   avoided	   by	   antiretroviral	  treatment,	  early	  diagnosis	  is	  important.	  	  In	  an	  attempt	  to	  decrease	  the	  child	  burden	  of	  disease	  the	  World	  Heath	  Organisation	  (WHO)	   and	   United	   Nations	   International	   Children's	   Emergency	   Fund’s	   (UNICEF)	  developed	   the	   Integrated	   Management	   of	   Childhood	   Illness	   (IMCI)	   that	   was	  implemented	  in	  Tanzania	  starting	  in	  1996	  (6).	  The	  IMCI	  strategy	  aspires	  to	  improve	  the	  management	   of	   common	   childhood	   illnesses	   at	   primary	   health	   care	   level	   by	   enabling	  early	   diagnosis	   and	   effective	   treatment.	   However,	   at	   first	   these	   guidelines	   did	   not	  specifically	  include	  HIV.	  In	  Tanzania	  and	  other	  high	  HIV	  prevalence	  countries	  IMCI	  was	  therefore	   revised	   to	   incorporate	   a	   new	   branch	   in	   the	   algorithm	   that	   would	   help	   to	  identify	   HIV	   exposed	   or	   infected	   children	   and	   provide	   guidelines	   on	   how	   to	   manage	  them.	  This	  branch,	  that	  was	  incorporated	  in	  the	  2008	  WHO	  generic	  version	  of	  IMCI,	  first	  allows	  to	  assess	  children	  potentially	  infected	  by	  HIV	  by	  determining	  if	  they	  fulfil	  enough	  criteria	  (at	  least	  2	  or	  3	  among	  7,	  according	  to	  the	  version	  of	  the	  algorithm)	  of	  suspected	  HIV	   infection,	   in	   order	   to	   refer	   the	   child	   to	   a	   voluntary	   testing	   and	   counselling	   (VTC)	  clinic	  for	  further	  HIV	  evaluation	  and	  management.	  Those	  7	  criteria	  include:	  pneumonia,	  persistent	  diarrhoea,	  ear	  discharge,	  oral	  thrush,	  parotid	  swelling,	  low	  weight	  for	  age	  and	  enlarged	  lymph	  glands(7).	  In	  the	  next	  English	  WHO	  generic	  version	  of	  IMCI	  of	  2014	  the	  clinical	  criteria	  have	  been	  removed	  and	  the	  algorithm	  is	  only	  based	  on	  the	  results	  of	  the	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mother	   and	   child’s	   serological	   or	   virological	   tests	   (8).	   This	   change,	   which	   aims	   at	  increasing	   the	   number	   of	   children	   tested,	   implies	   however	   that	   HIV	   rapid	   tests	   are	  available	   at	   all	   place	   and	   time,	  which	   is	   often	   not	   the	   case	   in	  many	   settings	   in	  Africa.	  Therefore,	  in	  their	  locally	  adapted	  version	  of	  IMCI,	  many	  countries	  have	  decided	  to	  keep	  the	   clinical	   criteria	   to	   decide	   on	  HIV	   testing,	   also	   because	   of	   the	   lack	   of	   time	   in	   busy	  health	   facilities	  to	  test	  each	  child	  attending	  for	  acute	  care.	  For	  example,	   the	  Tanzanian	  version	   of	   IMCI	   algorithm	   of	   2012	   uses	   the	   clinical	   criteria	   listed	   above	   with	   an	  additional	  criteria:	  history	  of	  tuberculosis	  in	  child,	  siblings	  or	  parents	  and	  a	  cut-­‐off	  of	  ≥3	  criteria	   to	   decide	   on	   the	   management	   of	   the	   child,	   taking	   into	   account	   whether	   HIV	  testing	  is	  available	  or	  not	  (9).	  	  The	  HIV	  branches	  of	   IMCI	  have	  had	   limited	  assessment	  since	   their	   implementation	  and	  little	  is	  known	  about	  the	  real	  performance	  of	  theirs	  criteria	  when	  confronted	  to	  data	  on	  documented	  HIV	  infection.	  Indeed,	  the	  criteria	  used	  do	  not	  necessarily	  correspond	  to	  the	  best	  clinical	  predictors	  of	  HIV	  infection	  in	  children,	  as	  little	  is	  know	  on	  this	  subject.	  A	  few	  studies	  have	  looked	  at	  the	  clinical	  presentation	  of	  HIV	  in	  African	  children	  and	  have	  investigated	   and	   identified	   clinical	   predictors	   of	   the	   infection.	   However,	  most	   studies	  were	  focused	  on	  children	  aged	  less	  than	  two	  years	  and	  only	  limited	  data	  regarding	  older	  children	   is	   available	   (10),	   (11),	   (12),	   (13),	   (14),	   (15),	   (16).	   Furthermore	   numbers	   of	  them	   were	   conducted	   on	   hospitalized	   children,	   including	   severely	   ill	   children	   with	   a	  high	  HIV	  prevalence	  and	  advanced	  stage	  of	  the	  disease	  (10),	  (17),	  (18),	  (19),	  (20).	  Two	  of	   these	   studies	   were	   conducted	   in	   Tanzania:	   one	   in	   1995	   on	   children	   aged	   from	   18	  months	  to	  5	  years,	  attending	  maternal	  and	  child	  health	  clinics	  in	  Dar	  es	  Salaam,	  before	  the	   beginning	   of	   IMCI	   implementation	   in	   1996(21);	   the	   other	   one	   in	   2000	   on	  hospitalized	   children	   aged	   from	   1	  month	   to	   7	   years	   (17).	   It	   is	   therefore	   necessary	   to	  conduct	  new	  studies	  to	  assess	  the	  performance	  of	  the	  HIV	  branch	  of	  the	  IMCI	  in	  a	  larger	  age	   range	   and	   determine	  which	   are	   the	  most	   adequate	   predictors	   of	  HIV	   for	   primary	  health	  care	  use.	  The	  aim	  of	  the	  present	  study	  is	  to	  identify	  the	  clinical	  predictors	  of	  the	  HIV	  infection	  in	   febrile	   children	   attending	   outpatient	   clinics	   in	   Tanzania	   and	   to	   calculate	   their	  diagnostic	   performance.	   For	   this	   purpose,	   we	   used	   data	   from	   a	   prospective	   study	   on	  etiologies	  of	  fever	  in	  children	  aged	  less	  than	  10	  years	  attending	  health	  facilities	  in	  rural	  and	  urban	  Tanzania,	  which	  was	   conducted	   in	   2008.	  All	   elements	   of	   a	   detailed	  history	  taking,	  clinical	  examination,	  laboratory	  investigations	  and	  final	  diagnoses	  based	  on	  pre-­‐defined	  criteria	  had	   indeed	  been	  collected.	  The	  other	  aim	  of	   this	  study	   is	   to	  assess	  the	  performance	  of	  the	  IMCI	  criteria	  and	  algorithm	  used	  in	  Tanzania	  at	  the	  time	  of	  the	  study	  and	  determine	  if	  a	  combination	  of	  new	  predictors	  have	  better	  diagnostic	  performance.	  
	  
2.	  Methods	  This	  study	  is	  a	  nested	  case-­‐control	  analysis	  in	  a	  prospective	  observational	  study	  on	  etiologies	   of	   fever	   in	   consecutive	   children	   attending	   outpatient	   clinics.	   Study	   sites,	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population,	   participants	   and	   procedures	   have	   already	   been	   described	   in	   detail	   in	  another	   article	   (22).	   Here	   is	   a	   summary	   of	   the	   methodology	   that	   is	   relevant	   for	   this	  study.	  
2.1	  Study	  sites	  and	  population	  The	  study	  took	  place	  in	  the	  United	  Republic	  of	  Tanzania,	  located	  within	  the	  great	  lake	  region	   in	   east	   Africa.	   In	   2008,	   year	   of	   the	   data	   collection,	   the	   total	   population	   of	   the	  country	  was	  42’354’000,	  45%	  of	  which	  were	  aged	  under	  15	  years	  (23).	  The	  overall	  HIV	  prevalence	   in	   adults	   aged	   15	   to	   49	   years	  was	   5.7%	   in	   2009;	   it	   has	   then	   decreased	   to	  5.1%	  in	  2011	  (Figure	  1)	  and	  5.0%	  in	  2013(23).	  This	  decline	  has	  however	  been	  observed	  in	  men,	  but	  unfortunately	  not	  in	  women.	  As	  a	  result,	  in	  2013	  a	  total	  of	  1.2	  millions	  adults	  aged	   over	   15	  were	   living	  with	   HIV,	   690’000	   of	  which	   being	  women	   (4).The	   study	   on	  etiologies	  of	  fever	  included	  two	  different	  sites.	  The	  first	  site	  was	  located	  in	  urban	  Dar	  es	  Salaam:	  children	  were	  recruited	  from	  April	  to	  August	  2008	  at	  the	  outpatient	  clinic	  of	  the	  Amana	  District	  Hospital,	  one	  of	   the	   three	  district	  hospitals	  of	   the	  city.	  The	  second	  site	  was	   located	   in	   the	   rural	   Morogoro	   region:	   children	   were	   recruited	   from	   June	   to	  December	  2008	  at	  the	  outpatient	  clinic	  of	  the	  St.	  Francis	  Designated	  District	  Hospital	  in	  Ifakara,	  Kilombero	  District.	  	  In	   Dar	   es	   Salaam,	   the	   Tanzania’s	   largest	   and	   richest	   city	   which	   is	   considered	   the	  economical	  and	  administrative	  capital	  of	  the	  country,	  the	  rate	  of	  HIV	  infection	  reached	  6.9%	  in	  2012,	  whereas	  in	  Morogoro	  region,	  a	  rural	  region	  situated	  500	  km	  South-­‐West	  of	  Dar	  es	  Salaam,	  	  the	  rate	  was	  only	  3.8%	  in	  the	  same	  year	  (24).	  
	  
Figure	  1:	  HIV	  prevalence	  by	  region	  and	  by	  residence	  in	  2011-­‐2012,	  and	  trend	  in	  HIV	  prevalence	  in	  the	  Mainland	  of	  Tanzania	  (25).	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2.2	  Participants	  Consecutive	   patients	   aged	   from	   2	  months	   to	   10	   years	   presenting	   with	   an	   axillary	  temperature	  of	  38°C	  or	  higher	  were	  screened	  for	  study	  inclusion.	  Children	  with	  severe	  malnutrition	   or	   presenting	   with	   emergency	   signs	   requiring	   immediate	   care	   were	  excluded.	  Four	  additional	  criteria	  of	  inclusion	  were	  applied:	  children	  were	  included	  if	  it	  was	  their	   first	  visit	   for	   the	  present	  disease,	   if	   fever	  duration	  was	  1	  week	  or	   less,	   if	   the	  main	   reason	  of	   their	   visit	  was	  neither	   trauma	  nor	   injury	   and	   if	   they	  had	  not	   received	  antimalarials	  or	  antibiotics	  during	  the	  preceding	  week.	  
2.3	  Clinical	  assessment	  All	  relevant	  elements	  related	  to	  an	  acute	  fever	  episode,	   including	  a	  detailed	  clinical	  history	  and	  physical	  examination,	  were	  obtained	  using	  standardized	  case-­‐report	  forms.	  Chief	   reason	   for	   the	  visit,	  23	  clinical	   symptoms	  and	   their	  duration,	  49	  clinical	   signs	  as	  well	   as	   travel	   history,	   contact	   with	   sick	   persons	   and	   known	   chronic	   conditions	   were	  assessed.	  
2.4	  Sample	  collection	  and	  laboratory	  testing	  For	  every	  child,	  pooled	  nasal	  and	  throat	  swabs	  as	  well	  as	  blood	  samples	  (5ml)	  were	  gathered	   for	   microbiological	   testing	   (rapid	   tests	   and	   cultures)	   on	   site	   and	   additional	  molecular	   and	   serologic	  work	   up	   in	   Switzerland	   and	   the	   United	   States.	   In	   all	   cases,	   a	  systematic	   set	   of	   investigations	   was	   made	   that	   included:	   full	   blood	   count,	   creatinine,	  alanine	   transaminase	   (ALT),	   polymerase	   chain	   reaction	   (PCR)	   on	   naso-­‐pharyngeal	  swabs	  for	  14	  viruses	  and	  4	  bacteria,	  PCR	  on	  blood	  for	  parvovirus	  B19	  and	  human	  herpes	  virus	  6	   (HHV6),	   blood	   slide	   for	  Malaria	   and	  Borrelia,	   rapid	  diagnostic	   test	   for	  Malaria	  and	   Salmonella	   typhi.	   Further	   investigations,	   including	   chest	   x-­‐ray	   and	   additional	  microbiological	   testing,	   were	   done	   according	   to	   several	   predefined	   non-­‐mutually	  exclusive	  decision	  charts	  elaborated	  for	  the	  chief	  symptoms	  of	  the	  child.	  Final	  diagnoses	  were	  established	  using	  sets	  of	  predefined	  criteria	  (clinical	  and	  microbiological)	  based	  on	  systematics	  reviews	  and	  on	  WHO	  and	  Infectious	  Diseases	  Society	  of	  America	  guidelines.	  Regarding	  HIV	   infection,	  during	   the	  study	  VCT	  was	   recommended	  according	   to	   the	  IMCI	  guidelines	  available	  at	  the	  time	  of	  the	  study,	  i.e.	  every	  time	  that	  at	  least	  2	  of	  the	  7	  IMCI	  clinical	  criteria	  for	  suspected	  HIV	  infection	  were	  met.	  Those	  7	  criteria	  were:	  history	  of	   persistent	   diarrhoea,	   ear	   discharge,	   very	   low	   weight	   for	   age,	   oral	   thrush,	   parotid	  swelling,	  pneumonia	  and	  enlarged	   lymph	  nodes	   in	   two	  or	  more	  of	   the	   following	  sites:	  neck,	  armpit	  or	  groin.	  With	  the	  approval	  of	  their	  guardians,	  those	  children	  were	  referred	  to	  the	  VCT	  clinic	  of	  the	  hospital	  in	  order	  to	  be	  tested	  for	  HIV.	  	  HIV	   testing	   was	   systematically	   conducted	   later	   in	   Switzerland	   on	   the	   blood	   of	   all	  children,	   independently	  of	   the	   IMCI	  criteria,	  using	  SD	  BIOLINE	  HIV-­‐1/2	  3.0	  Rapid	  Test	  (Standard	  Diagnostics	  Inc,	  Korea).	  Children	  under	  18	  months	  whose	  results	  came	  back	  positive	  were	  then	  tested	  by	  PCR	  to	  differentiate	  those	  HIV	  exposed	  from	  those	  actually	  infected.	  INSTI	  HIV-­‐1/HIV-­‐2	  Rapid	  Antibody	  Test	  (bioLytical	  Laboratories	  Inc,	  Canada)	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was	   used	   to	   confirm	   all	   positive	   results	   in	   children	   aged	   over	   18	  months.	   Discordant	  results	  were	  submitted	  to	   immunoblots,	   INNO-­‐LIA	  HIV	  I/II,	   Innogenetics,	   to	  determine	  the	   final	   status	  of	   the	  child.	  Positive	  HIV	  cases	  were	  defined	  as	  a	   child	  with	  a	  positive	  rapid	  test	  result	  and	  a	  PCR	  positive	  result	  in	  children	  aged	  less	  than	  18	  months	  and	  as	  either	   a	   positive	   rapid	   test	   result	   and	   an	   immunoblots	   positive	   result	   or	   two	   positive	  rapid	   tests	  results	   for	  children	  over	  18	  months.	  HIV	  exposed	  children	  were	  defined	  as	  those	   aged	   less	   than	   18	  months	  with	   a	   positive	   rapid	   test	   result	   and	   a	   negative	   PCR	  result.	  
2.5	  Analysis	  Data	   were	   analysed	   using	   Stata/MP	   version	   13.0	   (college	   station,	   Texas	   USA).	   All	  available	   variables	   were	   included	   in	   the	   analysis	   except	   those	   that	   were	   present	   or	  abnormal	  in	  less	  than	  10	  children	  to	  avoid	  results	  with	  very	  large	  confidence	  intervals.	  	  Variables	   were	   tested	   in	   bivariate	   analysis	   using	   chi-­‐squared	   test	   to	   measure	  differences	   between	  HIV-­‐positive	   and	  HIV-­‐negative	   children.	   Simple	  proportions	  were	  used	   to	   calculate	   sensitivity,	   specificity,	   positive	   and	   negative	   likelihood	   ratios.	  Predictors	  were	  considered	  as	  significant	  if	  the	  p-­‐value	  was	  lower	  than	  0.1.	  Continuous	  parameters	   were	   recoded	   in	   dichotomous	   ones	   using	   acceptable	   threshold	   for	  normality.	   Significant	   variables	   were	   then	   divided	   in	   four	   different	   groups,	   the	   first	  including	   context	   factors	   and	   symptoms	   that	   could	   be	   gathered	  during	  history	   taking,	  the	  second	  clinical	  signs	  obtained	  by	  the	  physical	  examination,	  the	  third	  the	  laboratory	  findings	   and	   the	   fourth	   final	   diagnoses	   based	   on	   predefined	   criteria.	   When	   two	  parameters	  had	  similar	  clinical	  meaning,	  only	  the	  most	  relevant	  one	  was	  included	  in	  the	  model.	   Each	   variables	   group	   was	   analysed	   separately	   in	   multivariate	   analyses	   using	  stepwise	   backward	   logistic	   regression	  models	   to	   calculate	   its	   variables	   adjusted	  Odds	  Ratios	  (aOR)	  and	  95%	  confidence	  intervals	  (95%CI).	  	  Then,	   the	   diagnostic	   performance	   of	   the	   Tanzanian	   IMCI	   HIV	   branch	   and	   criteria	  used	   at	   the	   time	   of	   the	   study	   was	   calculated.	   New	   algorithms	   using	   the	   best	   clinical	  predictors	  found	  in	  the	  analysis	  were	  generated	  to	  compare	  their	  performance	  with	  the	  actual	  IMCI	  HIV	  branch.	  	  	  
3.	  Results	  
3.1	  Description	  of	  the	  study	  sample	  A	  total	  of	  1005	  children	  were	  included	  in	  the	  study	  on	  etiologies	  of	  fever,	  507	  in	  Dar	  es	   Salaam	   and	   498	   in	   Ifakara.	   A	   child	   enrolled	   in	   Ifakara	   was	   then	   excluded	   of	   the	  analyses	  because	   its	  HIV	  status	  could	  not	  be	  determined	  due	   to	   the	   lack	  of	  blood.	  The	  overall	  median	  age	  was	  18.2	  months	  and	  48.5%	  of	  the	  children	  were	  female.	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Among	   the	   1004	   febrile	   children,	   16	   were	   found	   to	   be	   HIV	   positive	   and	   8	   HIV	  exposed.	  The	  overall	  HIV	  infection	  prevalence	  was	  1.6%	  and	  respective	  sites	  prevalence	  were	  1.2%	  in	  Dar	  es	  Salaam	  and	  2.0%	  in	  Ifakara	  (p-­‐value=0.3).	  Demographic	  and	  clinical	  characteristics	  of	  the	  febrile	  children	  of	  both	  sites	  are	  listed	  in	  Table	  1.	  	  
Table	  1:	  Demographic	  and	  clinical	  characteristics	  of	  the	  patients	  according	  to	  study	  site	  
Characteristic	  





No.	  (%)	  Female	  sex	   237	  (46.7)	   250	  (50.3)	  Age	  groupe	   	   	  2	  to	  <12	  months	   150	  (29.6)	   176	  (35.4)	  12	  to	  <36	  months	   228	  (45.0)	   226	  (45.5)	  36	  to	  <60	  months	   75	  (14.8)	   85	  (17.1)	  5	  to	  <8	  years	   36	  (7.1)	   8	  (1.6)	  8	  to	  <11	  years	   18	  (3.6)	   2	  (0.4)	  Weight	  for	  age	   	   	  Normal	   277/498	  (55.6)	   291/496	  (58.7)	  1	  SD	  below	  mean	   150/498	  (30.1)	   147/496	  (29.6)	  2	  SD	  below	  mean	   52/498	  (10.4)	   48/496	  (9.7)	  3	  SD	  below	  mean	   16/498	  (3.2)	   10/496	  (2.0)	  4	  SD	  below	  mean	   3/498	  (0.6)	   0/496	  (0.0)	  HIV-­‐positive	   6	  (1.2)	   10	  (2.0)	  HIV-­‐exposed	   4	  (0.8)	   4	  (0.8)	  Chief	  symptom	  reported	  by	  the	  guardian	   	   	  Fever	   313/497	  (63.0)	   353/494	  (71.5)	  Cough	   56/497	  (11.3)	   47/494	  (9.5)	  Vomiting	   47/497	  (9.5)	   28/494	  (5.7)	  Diarrhea	   33/497	  (6.6)	   22/494	  (4.5)	  Abdominal	  pain	   15/497	  (3.0)	   19/494	  (3.8)	  Other	   33/497	  (6.6)	   25/494	  (5.1)	  Diagnoses	   	   	  Acute	  respiratory	  	  	  	  infection	   248	  (48.9)	   376	  (75.7)	  Malaria	   60	  (11.8)	   44	  (8.9)	  Gastroenteritis	   45	  (8.9)	   58	  (11.7)	  Urinary	  tract	  infection	   39	  (7.7)	   20	  (4.0)	  Viral	  disease	   307	  (60.6)	   401	  (80.7)	  Bacterial	  disease	   128	  (25.2)	   93	  (18.7)	  Parasitic	  disease	   61	  (12.0)	   47	  (9.5)	  Severe	   90	  (17.8)	   43	  (8.7)	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3.2	  Characteristics	  of	  HIV	  positives	  cases	  For	   the	  16	  children	  diagnosed	  with	  HIV	   infection,	  44%	  (7/16)	  were	  girls	  and	  38%	  (6/16)	  were	   attending	   the	   outpatient	   clinic	   of	   Dar	   es	   Salaam.	   The	   age	   of	   the	   subjects	  ranged	  from	  4	  to	  59	  months	  and	  the	  median	  age	  was	  18	  months.	  The	  chief	  reason	  for	  the	  visit	  mentioned	   by	   the	   guardian	  was	   fever	   in	   6	   cases,	   cough	   in	   4	   cases,	   diarrhea	   in	   2	  cases,	  vomiting	  in	  2	  cases	  and	  running	  nose	  in	  1	  case	  (unknown	  for	  one	  child).	  5	  (31%)	  of	  the	  16	  HIV	  infected	  children	  were	  already	  known	  to	  suffer	  from	  a	  chronic	  condition:	  2	  had	   presented	   recurrent	   fever,	   1	   recurrent	   chest	   infection,	   1	   scalp	   fungus	   and	   1	  was	  already	   known	   to	   be	   HIV	   infected.	   Clinical	   pneumonia	   was	   the	   most	   frequent	   final	  diagnosis	  for	  the	  febrile	  episode	  and	  was	  present	  in	  9	  of	  the	  children,	  4	  of	  which	  were	  classified	   as	   severe	   clinical	   pneumonia.	   Of	   those	   9	   clinical	   pneumonias,	   6	   were	  radiological	  end-­‐point	  pneumonias	  (as	  defined	  by	  WHO)	  (26),	  while	  the	  chest	  x-­‐ray	  was	  normal	  for	  the	  other	  3.	  Other	  diagnoses	  (7/16	  children	  had	  multiple	  diagnoses)	  were	  3	  gastroenteritis,	  3	  typhoid,	  2	  jaundice,	  2	  exanthemas	  of	  unknown	  origin,	  2	  bronchiolitis,	  2	  acute	   otitis	  media,	   1	  HHV6	  acute	   infection,	   1	  malaria	   and	  1	   elevated	   liver	   enzymes	  of	  unknown	  origin.	  
3.3	  Clinical	  predictors	  of	  HIV	  infection	  A	  total	  of	  6	  symptoms,	  18	  clinical	  signs,	  5	   laboratory	  findings	  and	  7	  final	  diagnoses	  were	  found	  to	  be	  significantly	  associated	  with	  HIV	  infection	  in	  the	  bivariate	  analysis	  (see	  Table	  2).	  Overall,	  the	  strongest	  predictors	  of	  HIV	  infection	  were:	  radiological	  end-­‐point	  pneumonia	  (OR	  23.1,	  95%	  CI	  7.5-­‐71.1),	  lymphadenopathy	  at	  any	  site	  (OR	  18.4,	  6.3-­‐53.6)	  -­‐	   armpit	   being	   the	   localisation	   with	   the	   strongest	   association	   (OR	   32.6,	   8.6-­‐124.1),	  followed	  by	  ≥	  2	  sites	  (OR	  25.1,	  5.9-­‐106.8),	  groin	  (OR	  25.0,	  6.9-­‐91.0)	  and	  neck	  (OR	  7.6,	  2.0-­‐28.5)	  -­‐,	  hepatomegaly	  (OR	  14.6,	  4.9-­‐43.2),	  fast	  breathing	  (respiratory	  rate	  ≥50/min	  for	  children	  <12	  months	  or	  ≥40/min	  for	  children	  ≥12	  months)	  (OR	  14.3,	  4.0-­‐51.5),	  chest	  indrawing	  (OR	  14.0,	  4.1-­‐47.6),	  nose	  flapping	  (OR	  11.8,	  3.1-­‐45.4)	  and	  splenomegaly	  (OR	  11.1,	  3.6-­‐33.9).	  
Table	   2:	   Demographics	   and	   symptoms,	   clinical	   signs,	   laboratory	   findings	   and	   final	  
diagnoses	  predictive	  of	  HIV	  infection	  in	  1004	  febrile	  children	  (bivariate	  analysis).	  








(N=988)	   OR	   (95%	  CI)	   p-­‐value	  
N	  (%)	   N	  (%)	   N	  (%)	  Sick	  contact	  person	   91/1003	  (9.1)	   4	  (25.0)	   87/987	  (8.8)	   3.4	   1.1-­‐11.0	   0.03	  Chronic	  condition	   70/1003	  (7.0)	   5	  (31.3)	   65/987	  (6.6)	   6.4	   2.2-­‐19.3	   <0.001	  Recent	  travel	  history	   48/1001	  (4.8)	   3	  (18.8)	   45/985	  (4.6)	   4.8	   1.3-­‐17.6	   0.008	  Difficulty	  to	  drink/breastfeed	   12	  (1.2)	   1	  (6.3)	   11	  (1.1)	   5.9	   0.7-­‐49.1	   0.06	  Breahting	  difficulty	   20	  (2.0)	   2	  (12.5)	   18	  (1.8)	   7.7	   1.6-­‐36.7	   0.002	  Cough	   458	  (45.6)	   11	  (68.8)	   447	  (45.2)	   2.7	   0.9-­‐7.7	   0.06	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Clinical	  signs	  
Overall	   HIV+	   HIV-­‐	  
OR	   (95%	  CI)	   p-­‐value	  
N	  (%)	   N	  (%)	   N	  (%)	  Low	  weight	  for	  age	  (≤	  2SD)	   129/994	  (13.0)	   8	  (50.0)	   121/978	  (12.4)	   7.1	   2.6-­‐19.4	   <0.001	  High	  Temperature	  (≥	  40°C)	   37	  (3.7)	   2	  (12.5)	   35	  (3.5)	   3.9	   0.8-­‐17.8	   0.06	  Tachychardia1	   193/991	  (19.5)	   9	  (56.3)	   184/975	  (18.9)	   5.5	   2.0-­‐15.2	   <0.001	  Fast	  breathing2	   243	  (24.2)	   13	  (81.3)	   230	  (23.3)	   14.3	   4.0-­‐51.5	   <0.001	  Abnormal	  chest	  auscultation	   108	  (10.8)	   5	  (31.3)	   103	  (10.4)	   3.9	   1.3-­‐11.5	   0.008	  Chest	  indrawing	   27	  (2.7)	   4	  (25.0)	   23	  (2.3)	   14.0	   4.1-­‐47.6	   <0.001	  Nose	  flapping	   22	  (2.2)	   3	  (18.8)	   19	  (1.9)	   11.8	   3.1-­‐45.4	   <0.001	  Abdominal	  tenderness	   33	  (3.3)	   3	  (18.8)	   30	  (3.0)	   7.4	   2.0-­‐27.5	   <0.001	  Hepatomegaly	   45	  (4.5)	   6	  (37.5)	   39	  (3.9)	   14.6	   4.9-­‐43.2	   <0.001	  Splenomegaly	   44	  (4.4)	   5	  (31.3)	   39	  (3.9)	   11.1	   3.6-­‐33.9	   <0.001	  Jaundice	   42	  (4.2)	   2	  (12.5)	   40	  (4.0)	   3.4	   0.7-­‐15.4	   0.09	  Oral	  thrush	   13	  (1.3)	   1	  (6.3)	   12	  (1.2)	   5.4	   0.7-­‐44.6	   0.08	  Oral	  ulcers	   39	  (3.9)	   2	  (12.5)	   37	  (3.7)	   3.7	   0.8-­‐16.8	   0.07	  Lymphadenopathy	   	   	   	   	   	   	   	   	   	  -­‐	  any	  site	   47	  (4.7)	   7	  (43.8)	   40	  (4.0)	   18.4	   6.3-­‐53.6	   <0.001	  -­‐	  ≥	  2	  sites	   12	  (1.2)	   3	  (18.8)	   9	  (0.9)	   25.1	   5.9-­‐106.8	   <0.001	  -­‐	  neck	   32	  (3.2)	   3	  (18.8)	   29	  (2.9)	   7.6	   2.0-­‐28.5	   <0.001	  -­‐	  armpit	   14	  (1.4)	   4	  (25.0)	   10	  (1.0)	   32.6	   8.6-­‐124.1	   <0.001	  -­‐	  groin	   17	  (1.7)	   4	  (25.0)	   13	  (1.3)	   25.0	   6.9-­‐91.0	   <0.001	  	   	   	   	   	   	   	   	   	   	  
Laboratory	  findings	  
Overall	   HIV+	   HIV-­‐	  
OR	   (95%	  CI)	   p-­‐value	  
N	  (%)	   N	  (%)	   N	  (%)	  Anemia	  (Hb<8g/dl)	   138	  (13.7)	   6	  (37.5)	   132	  (13.4)	   3.9	   1.4-­‐10.9	   0.005	  Presence	  of	  NP	  Enterovirus	  	   40	  (4.0)	   1	  (6.3)	   39	  (3.9)	   1.6	   0.2-­‐12.6	   0.6	  Presence	  of	  NP	  Influenza	  virus	  	   190	  (18.9)	   0	  (0.0)	   190	  (19.2)	   0.0	   .-­‐.	   0.05	  Presence	  of	  NP	  
Staphylococcus	  
aureus	  	   212/908	  (23.3)	   7/15	  (46.7)	   205/893	  (23.0)	   2.9	   1.0-­‐8.2	   0.03	  High	  NP	  
Streptococcus	  
pneumoniae	  load3	   144/1000	  (14.4)	   5	  (31.3)	   139/984	  (14.1)	   2.8	   0.9-­‐8.1	   0.05	  	   	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Heart	  rate	  >140/min	  for	  children	  <12	  months,	  >130/min	  for	  children	  12-­‐≤24	  months,	  >120	  for	  2	  Respiratory	  rate	  ≥50/min	  for	  children	  <12	  months	  or	  ≥40/min	  for	  children	  ≥12	  months.	  3	  ≥107	  cfu/ml	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Final	  diagnoses	  
Overall	   HIV+	   HIV-­‐	  
OR	   (95%	  CI)	   p-­‐value	  
N	  (%)	   N	  (%)	   N	  (%)	  Severe	  illness	   133	  (13.2)	   6	  (37.5)	   127	  (12.9)	   4.1	   1.4-­‐11.4	   0.004	  Bacterial	  disease	   221	  (22.0)	   9	  (56.3)	   212	  (21.5)	   4.7	   1.7-­‐12.9	   0.001	  Clinical	  pneumonia4	   151	  (15.0)	   9	  (56.3)	   142	  (14.4)	   7.7	   2.8-­‐21.1	   <0.001	  Radiological	  end-­‐point	  pneumonia	  	   31	  (3.1)	   6	  (37.5)	   25	  (2.5)	   23.1	   7.5-­‐71.1	   <0.001	  Bronchiolitis	   35	  (3.5)	   2	  (12.5)	   33	  (3.3)	   4.1	   0.9-­‐19.0	   0.05	  Upper	  respiratory	  tract	  infection	   438	  (43.6)	   2	  (12.5)	   436	  (44.1)	   0.2	   0.0-­‐0.8	   0.01	  Acute	  otitis	  media	   24	  (2.4)	   2	  (12.5)	   22	  (2.2)	   6.3	   1.3-­‐29.5	   0.008	  	  
3.3.1	  Demographics	  and	  symptoms	  In	   the	   bivariate	   analysis,	   a	   total	   of	   6	   variables	   were	   found	   to	   be	   significantly	  associated	  with	  the	  HIV	  infection:	  difficulty	  to	  breath	  (OR	  7.7,	  1.6-­‐36.7),	  suffering	  from	  a	  chronic	  condition	  (OR	  6.4,	  2.2-­‐19.3),	  difficulty	  to	  drink	  or	  breastfeed	  (OR	  5.9,	  0.7-­‐49.1),	  having	  travelled	  out	  of	  the	  district	  in	  the	  last	  month	  (OR	  4.8,	  1.3-­‐17.6),	  having	  a	  contact	  person	  presently	  sick	  (OR	  3.4,	  1.1-­‐11.0)	  and	  cough	  (OR	  2.7,	  0.9-­‐7.7)	  (see	  Table	  2).	  The	  most	   sensitive	   predictor	   of	   HIV	   infection	   was	   cough	   [sensitivity	   (se)	   68.8%]	   and	   the	  most	  specific	  was	  difficulty	  to	  drink	  or	  breastfeed	  [specificity	  (sp)	  98.9%].	  	  Four	   of	   these	   predictors	   were	   still	   significantly	   associated	   with	   HIV	   in	   the	  multivariate	  analysis:	  chronic	  condition	  (aOR	  6.7,	  2.2-­‐20.4),	  difficulty	  to	  breath	  (aOR	  6.4,	  1.2-­‐32.9),	  recent	  travel	  history	  (aOR	  4.9,	  1.3-­‐18.8)	  and	  sick	  contact	  person	  (aOR	  3.1,	  0.9-­‐10.2).	   Their	   respective	   sensitivity,	   specificity,	   positive	   likelihood	   ratio	   (LR+),	   negative	  likelihood	  ratio	  (LR-­‐),	  aOR	  and	  95%	  CI	  are	  presented	  in	  Table	  3.	  	  







LR+	   LR-­‐	   aOR	   95%	  CI	  Chronic	  condition	   31.3	   93.4	   4.7	   0.7	   6.7	   2.2-­‐20.4	  Difficulty	  to	  breath	   12.5	   98.2	   6.9	   0.9	   6.4	   1.2-­‐32.9	  Recent	  travel	  history	   18.8	   95.4	   4.1	   0.9	   4.9	   1.3-­‐18.8	  Sick	  contact	  person	   25.0	   91.2	   2.8	   0.8	   3.1	   0.9-­‐10.2	  	  
3.3.2	  Clinical	  signs	  Analysis	  of	  the	  clinical	  signs	  in	  the	  bivariate	  analysis	  showed	  that	  lymphadenopathy	  at	   any	   site	   (OR	   18.4,	   6.3-­‐53.6)	   -­‐	   armpit	   being	   the	   localisation	   with	   the	   strongest	  association	   (OR	  32.6,	  8.6-­‐124.1),	   followed	  by	  ≥	  2	   sites	   (OR	  25.1,	  5.9-­‐106.8),	   groin	   (OR	  25.0,	   6.9-­‐91.0)	   and	   neck	   (OR	   7.6,	   2.0-­‐28.5)	   -­‐,	   hepatomegaly	   (OR	   14.6,	   4.9-­‐43.2),	   fast	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  according	  to	  WHO	  criteria	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breathing5	  (OR	  14.3,	   4.0-­‐51.5),	   chest	   indrawing	   (OR	  14.0,	   4.1-­‐47.6),	   splenomegaly	   (OR	  11.1,	   3.6-­‐33.9),	   abdominal	   tenderness	   (OR	   7.4,	   2.0-­‐27.5),	   weight	   for	   age	   ≤2	   standard	  deviation	   (OR	   7.1,	   2.6-­‐19.4),	   tachycardia6	  (OR	   5.5,	   2.0-­‐15.2),	   oral	   thrush	   (OR	   5.4,	   0.7-­‐44.6),	  abnormal	  chest	  auscultation	  (OR	  3.9,	  1.3-­‐11.5),	   temperature	  ≥40°C	  (OR	  3.9,	  0.8-­‐17.8),	   oral	   ulcers	   (OR	  3.7,	   0.8-­‐16.8)	   and	   jaundice	   (OR	  3.4,	   0.7-­‐15.4)	  were	   significantly	  more	  common	  in	  HIV	  infected	  children	  compared	  to	  the	  negative	  children	  (see	  Table	  2).	  The	  predictor	  with	  highest	  sensitivity	  was	  fast	  breathing5	  (se	  81.3%),	  and	  the	  one	  with	  highest	  specificity	  was	  lymphadenopathy	  ≥	  2	  sites	  (sp	  98.9%).	  In	   the	   multivariate	   analysis,	   clinical	   signs	   predictive	   of	   HIV	   infection	   were:	  lymphadenopathy	  at	  any	  site	  (aOR	  21.0,	  5.3-­‐84.2),	  abdominal	  tenderness	  (aOR	  16.6,	  3.0-­‐91.3),	  fast	  breathing5	  (aOR	  10.7,	  2.5-­‐45.5),	  weight	  for	  age	  ≤2SD	  (aOR	  7.1,	  2.1-­‐24.6),	  chest	  indrawing	  (aOR	  6.9,	  1.3-­‐38.4)	  and,	  hepatomegalia	  (aOR	  4.5,	  1.1-­‐19.0).	  	  Their	  respective	  sensitivity,	   specificity,	   positive	   likelihood	   ratio	   (LR+),	   negative	   likelihood	   ratio	   (LR-­‐),	  aOR	  and	  95%	  CI	  are	  detailed	  in	  Table	  4.	  
Table	  4:	  Clinical	  signs	  predictive	  of	  HIV	  infection	  (multivariate	  analysis).	  
Clinical	  signs	   Sensitivity	  (%)	   Specificity	  (%)	   LR+	   LR-­‐	   aOR	   95%	  CI	  Lymphadenopathy	  at	  any	  site	   43.8	   96.0	   10.8	   0.6	   21.0	   5.3-­‐84.2	  Abdominal	  tenderness	   18.8	   97.0	   6.2	   0.8	   16.6	   3.0-­‐91.3	  Fast	  breathing5	   81.3	   76.7	   3.5	   0.2	   10.7	   2.5-­‐45.5	  Low	  weight	  for	  age	  (≤2SD)	   50.0	   87.6	   4.0	   0.6	   7.1	   2.1-­‐24.6	  Chest	  indrawing	   25.0	   97.7	   10.7	   0.8	   6.9	   1.3-­‐38.4	  Hepatomegaly	   37.5	   96.1	   9.5	   0.7	   4.5	   1.1-­‐19.0	  	  
3.3.3	  Laboratory	  findings	  Regarding	  laboratory	  findings,	  anemia	  (Hb<8g/dl)	  (OR	  3.9,	  1.4-­‐10.9)	  was	  found	  to	  be	  significantly	  more	  present	   in	  HIV	   infected	  children.	  The	  comparison	  of	   the	  analyses	  of	  various	  respiratory	  virus	  and	  bacteria	  PCR	  on	  nasopharyngeal	  (NP)	  swabs	  showed	  some	  significant	   differences:	   the	   presence	   of	   Staphylococcus	   aureus	   (OR	   2.9,	   1.0-­‐8.2)	   was	  predictive	  of	  HIV	  infection,	  the	  prevalence	  of	  Streptococcus	  pneumoniae	  was	  the	  same	  in	  both	   HIV	   positive	   and	   negative	   children	   (94%	   and	   84%	   respectively);	   however	   the	  bacteria	   load	  was	   significantly	  higher	   in	  HIV	  positive	   children	   (OR	  2.8,	  0.9-­‐8.1)	  with	  a	  threshold	  of	  107 cfu/ml).	  The	  presence	  of	  enterovirus	  (OR	  1.6,	  0.2-­‐12.6)	  in	  NP	  swabs	  was	  as	   well	   found	   to	   be	   associated	   with	   HIV	   infection.	   On	   the	   contrary,	   the	   presence	   of	  Influenza	   virus	   (OR	   0.0)	  was	   found	   to	   be	  more	   frequent	   in	   HIV	   negative	   than	   in	   HIV	  positive	  children	  (see	  Table	  2).	  The	  most	  sensitive	  predictor	  of	  HIV	  infection	  was	  found	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	  Respiratory	  rate	  ≥50/min	  for	  children	  <12	  months	  or	  ≥40/min	  for	  children	  ≥12	  months.	  6	  heart	  rate	  >140/min	  for	  children	  <12	  months,	  >130/min	  for	  children	  12-­‐≤24	  months,	  >120	  for	  children	  24-­‐≤58	  months,	  >110	  for	  children	  ≥58	  months	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to	   be	   the	   presence	   of	   NP	   Staphylococcus	  aureus	   (se	   46.7%)	   and	   the	  most	   specific	   the	  presence	  of	  nasopharyngeal	  enterovirus	  (sp	  96.1%).	  In	   the	   multivariate	   analysis,	   anemia	   (hb<8g/dl)	   (aOR	   4.1,	   1.4-­‐12.0),	   high	   NP	  
Streptococcus	  pneumoniae	   load	   (aOR	  3.6,	   1.2-­‐11.0)	   and	  presence	   of	  NP	  Staphylococcus	  
aureus	   (aOR	   3.5,	   1.2-­‐10.3)	  were	   found	   to	   be	   independent	   predictors	   of	   HIV	   infection.	  Their	   respective	   sensitivity,	   specificity,	   positive	   likelihood	   ratio	   (LR+),	   negative	  likelihood	  ratio	  (LR-­‐),	  aOR	  and	  95%	  CI	  are	  listed	  in	  Table	  5.	  






LR+	   LR-­‐	   aOR	   95%	  CI	  Anemia	  (Hb<8g/dl)	   37.5	   86.6	   2.8	   0.7	   4.1	   1.4-­‐12.0	  Presence	  of	  NP	  
Staphylococcus	  aureus	  	   46.7	   77.0	   2.0	   0.7	   3.5	   1.2-­‐10.3	  High	  NP	  Streptococcus	  
pneumoniae	  load7	   31.3	   85.9	   2.2	   0.8	   3.6	   1.2-­‐11.0	  	  
3.3.4	  Final	  diagnoses	  Comparison	   of	   final	   diagnoses	   by	   bivariate	   analysis	   showed	   that	   radiological	   end-­‐point	   pneumonia	   (OR	   23.1,	   7.5-­‐71-­‐1),	   acute	   otitis	   media	   (OR	   6.3,	   1.3-­‐29.5),	   suffering	  from	   any	   bacterial	   diseases	   (OR	   4.7,	   1.7-­‐12.9),	   bronchiolitis	   (OR	   4.1,	   0.9-­‐19.0)	   and	  presenting	   a	   severe	   illness	   (OR	   4.1,	   1.4-­‐11.4)	   were	   statistically	   associated	   with	   HIV	  infection.	  On	   the	  contrary,	   suffering	   from	  an	  upper	  respiratory	   tract	   infection	   (OR	  0.2,	  0.0-­‐0.8)	  was	  significantly	  more	  frequent	  in	  HIV	  negative	  children	  (see	  Table	  2).	  Suffering	  from	  a	  bacterial	  infection	  and	  being	  diagnosed	  with	  a	  clinical	  pneumonia	  were	  the	  most	  sensitive	  predictors	  of	  HIV	   infection	  both	  with	  a	   sensitivity	  of	  56%.	  The	  most	   specific	  predictor	  was	  acute	  otitis	  media	  (97.8%).	  
Table	  6:	  Final	  diagnoses	  predictive	  of	  HIV	  infection	  (multivariate	  analysis).	  
Final	  diagnoses	   Sensitivity	  (%)	   Specificity	  (%)	   LR+	   LR-­‐	   aOR	   95%	  CI	  Acute	  otitis	  media	   12.5	   97.8	   5.6	   0.9	   82.2	   5.8-­‐1159.6	  Radiological	  end-­‐point	  pneumonia	   37.5	   97.5	   14.8	   0.6	   19.5	   5.7-­‐66.5	  Bronchiolitis	   12.5	   96.7	   3.7	   0.9	   4.9	   0.9-­‐25.9	  Severe	  condition	   37.5	   87.1	   2.9	   0.7	   2.8	   0.9-­‐8.8	  Upper	  respiratory	  tract	  infection	   12.5	   55.9	   0.3	   1.6	   0.1	   0.0-­‐1.4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  ≥107 cfu/ml	  
	   16	  
Independent	   diagnoses	   predictive	   of	  HIV	   infection	  were	   acute	   otitis	  media	   (aOR	  82.2,	  5.8-­‐1159.6),	   radiological	  end-­‐point	  pneumonia	  (aOR	  19.5,	  5.7-­‐66.5),	  bronchiolitis	   (aOR	  4.9,	   0.9-­‐25.9)	   and	   severe	   illness	   (aOR	   2.8,	   0.9-­‐8.8).	   Having	   an	   upper	   respiratory	   tract	  infection	   (aOR	   0.1,	   0.0-­‐1.4)	   was	   independently	   associated	   with	   the	   fact	   of	   being	   HIV	  negative.	   Their	   respective	   sensitivity,	   specificity,	   positive	   likelihood	   ratio	   (LR+),	  negative	  likelihood	  ratio	  (LR-­‐),	  aOR	  and	  95%	  CI	  are	  detailed	  in	  Table	  6.	  	  
3.3.5	  HIV	  testing	  according	  to	  IMCI	  criteria	  The	   performance	   of	   the	   IMCI	   criteria	   used	   in	   Tanzania	   at	   the	   time	   of	   the	   study	   to	  decide	   on	   HIV	   testing	   are	   the	   following	   (in	   descending	   order	   of	   sensitivity):	   clinical	  pneumonia	   (se	   56.3%,	   sp	   85.6%),	   weight	   for	   age	   ≤2SD	   (se	   50.0%,	   sp	   87.6%),	  lymphadenopathy	  at	  ≥	  2	  sites	  including	  neck,	  armpit	  and	  groin	  (se	  18.8%,	  sp	  99.1%),	  ear	  discharge	  (se	  12.5%,	  sp	  99.5%),	  oral	  thrush	  (se	  6.3%,	  sp	  98.8%),	  persistent	  diarrhea	  (se	  6.3%,	  sp	  100%)	  and	  parotid	  swelling	  (found	  in	  only	  one	  child)	  (se	  0%,	  sp	  99.9%).	  Their	  respective	  sensitivity,	  specificity,	  positive	  likelihood	  ratio	  (LR+)	  and	  negative	  likelihood	  ratio	  (LR-­‐)	  are	  listed	  in	  Table	  7.	  






















(%)	   LR+	   LR-­‐	  1	  or	  more	  criteria	  for	  HIV	   15	  (93.8)	   260	  (26.3)	   93.8	   73.7	   3.6	   0.1	  2	  or	  more	  criteria	  for	  HIV	   9	  (56.3)	   28	  (2.8)	   56.3	   97.2	   19.8	   0.5	  3	  criteria	  for	  HIV	   0	  (0)	   2	  (0.2)	   0	   99.8	   0	   1.0	  	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  8	  according	  to	  WHO	  criteria	  9	  Including	  neck,	  armpit	  and	  groin	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Performance	   of	   the	   whole	   HIV	   branch	   was	   also	   assessed.	   When	   using	   only	   one	  criterion	  to	  classify	  the	  child	  for	  suspected	  HIV-­‐infection,	  15	  HIV	  positive	  children	  were	  detected	   by	   the	   algorithm	   (se	   93.8%,	   sp	   73.7%).	  When	   using	   2	   or	   more	   criteria,	   the	  algorithm	  detected	  9	  out	  of	  the	  16	  HIV-­‐positive	  children	  (se	  56.3%,	  sp	  97.2%)	  and	  when	  using	  3	  criteria	  none	  of	  the	  HIV-­‐positive	  children	  were	  detected	  (se	  0%,	  sp	  99.8%)(see	  Table	  7).	  
3.3.6	  New	  HIV	  algorithm	  	  New	  clinical	  HIV	  algorithms	  were	  generated	  using	   the	  best	  predictors	   found	   in	   the	  above	  analyses.	  The	  algorithm	  found	  to	  have	  the	  best	  global	  performance	   is	  presented	  here.	   Its	   diagnostic	   performance	   is	   the	   following:	   when	   using	   only	   one	   criterion	   to	  classify	   the	   child	   for	   suspected	  HIV-­‐infection,	   15	  out	  of	  16	  HIV-­‐positive	   children	  were	  detected	   by	   the	   algorithm	   (se	   93.8%,	   sp	   81.4%).	  When	   using	   2	   or	   more	   criteria,	   the	  algorithm	   detected	   10	   HIV-­‐positive	   children	   (se	   62.5%,	   sp	   97.4%)	   and	  when	   using	   3	  criteria	  only	  1	  HIV-­‐positive	  children	  was	  detected	  (se	  6.3%,	  sp	  99.8%)	  (see	  table	  8).	  The	  respective	  sensitivity,	  specificity,	  positive	  and	  negative	  likelihood	  ratios	  of	  each	  criteria	  used	  in	  the	  new	  algorithm	  are	  presented	  in	  table	  8.	  






















(%)	   LR+	   LR-­‐	  1	  or	  more	  criteria	  for	  HIV	   15	  (93.8)	   184	  (18.6)	   93.8	   81.4	   5.0	   0.1	  2	  or	  more	  criteria	  for	  HIV	   10	  (62.5)	   26	  (2.6)	   62.5	   97.4	   23.8	   0.4	  3	  criteria	  for	  HIV	   1	  (6.3)	   2	  (0.2)	   6.3	   99.8	   30.9	   0.9	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4.	  Discussion	  	  The	  HIV	  infection	  prevalence	  of	  1.6%,	  found	  in	  febrile	  children	  in	  the	  present	  study,	  is	  very	  close	   to	   the	  1.7%	  reported	   in	  a	  study	  realized	   in	  1995	   in	  Tanzania	  on	  children	  aged	   from	  18	  months	   to	  5	  years,	  attending	  maternal	  and	  child	  health	  clinics	   in	  Dar	  es	  Salaam	  (21).	  However,	  it	  is	  lower	  than	  previous	  studies	  conducted	  in	  Tanzania	  in	  2000	  in	   Nigeria,	   or	   Zimbabwe	   which	   included	   hospitalized	   children	   with	   more	   severe	  conditions,	  probably	  leading	  to	  a	  higher	  HIV	  prevalence	  and	  advanced	  AIDS	  stage	  (17),	  (27),	   (10).	   Nevertheless,	   it	   remains	   twice	   higher	   than	   the	   national	   estimated	   2015	  burden	  of	  HIV	  infection	  in	  children	  less	  than	  15	  years	  (whether	  sick	  or	  not)	  (28).	  Some	  of	  the	  clinical	  symptoms,	  signs	  and	  diagnoses	  found	  in	  the	  present	  study	  to	  be	  predictive	  of	  HIV	  infection	  correlate	  well	  with	  the	  known	  presentation	  of	  paediatric	  HIV	  infection.	   Several	   predictors	  were	   similar	   to	   those	   already	   published	   in	   other	   studies	  such	  as:	   low	  weight	   for	  age	  (10)	  (12)	  (17)	  (21)	  (27),	   lymphadenopathy	  (10)	  (12)	  (15)	  (17)	  (21)	  (27)	  (29),	  hepatomegaly	  (10),	  (12)	  (18),	  (27),	  splenomegaly	  (10),	  (12),	  (18),	  (27),	  jaundice	  (10),	  (27),	  pneumonia	  (13)	  (29)	  acute	  otitis	  media	  (13)	  (27),	  oral	  thrush	  (10),	  (12),	  (17),	  (18),	  (27),	  (29),	  and	  oral	  ulcers	  (10),	  (17),	  (29).	  	  Others	   predictors	   that	  we	   found	  were	  new	  and	  had	   to	   our	   knowledge,	   never	   been	  reported	   in	   previous	   studies.	   Sick	   contact	   person	   for	   example,	   was	   found	   to	   be	   an	  independent	  predictor	  of	  HIV	  infection.	  As	  HIV	  infection	  in	  children	  is	  most	  of	  the	  time	  due	   to	   mother-­‐to-­‐child-­‐transmission,	   this	   predictor	   can	   be	   explained	   by	   the	  consequence	  of	  the	  HIV	  infection	  on	  the	  health	  of	  other	  family	  members.	  Indeed,	  mother,	  father	  and/or	  other	  siblings	  may	  as	  well	  be	  HIV-­‐positive	  and	  consequently	  more	  often	  sick,	   or	  might	   be	   simply	   exposed	   to	  more	   infectious	   diseases	   brought	   in	   by	   the	   HIV-­‐positive	   member	   (as	   known	   for	   tuberculosis).	   The	   fact	   that	   travel	   history	   out	   of	   the	  district	  was	   a	   predictor	  may	   be	   explained	   by	   the	   possible	   suspicion	   by	   the	   guardians	  about	  their	  or	  the	  child’s	  positive	  HIV	  status	  that	  motivated	  them	  to	  travel	  to	  a	  district	  hospital	  having	  an	  HIV	  specialized	  clinic	  with	  the	  aim	  to	  get	  appropriate	  care.	  	  	  Anemia	   is	   a	   known	   feature	   of	   HIV	   infection	   but	   had	   to	   our	   knowledge	   not	   been	  formally	   reported	   as	   predictive	   of	   the	   infection.	   Difficulty	   to	   breath,	   cough,	   abnormal	  chest	   auscultation,	   fast	  breathing,	   chest	   indrawing	  and	  nose	   flapping	  are	  explained	  by	  the	  increased	  risk	  of	  HIV	  infected	  children	  to	  suffer	  from	  severe	  respiratory	  infections.	  The	  presence	  of	  Staphylococcus	  aureus	  and	  a	  high	   load	  of	  Streptococcus	  pneumoniae	   in	  the	  nasopharynx	  are	  very	  interesting	  predictors	  that	  can	  be	  explained	  by	  the	  tendency	  of	   HIV	   infected	   children	   to	   be	   colonised	   by	   bacteria	   at	   a	   higher	   rate,	   even	   before	  developing	  a	  symptomatic	   infection.	  Upper	  respiratory	   tract	   infection	  was	   found	   to	  be	  less	  prevalent	  in	  HIV	  positive	  children,	  whereas	  bronchiolitis	  and	  radiological	  end-­‐point	  pneumonia	   were	   predictive	   of	   the	   HIV	   infection,	   highlighting	   the	   tendency	   of	   HIV	  infected	  children	  to	  present	  more	  severe	  respiratory	  infections,	  possibly	  also	  more	  often	  due	  to	  bacteria	  than	  viruses.	  Indeed,	  the	  diagnosis	  of	  bacterial	  disease	  was	  found	  to	  be	  associated	  with	  the	  HIV	  infection.	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Other	   predictors	   such	   as	   difficulty	   to	   drink	   or	   breastfeed,	   temperature	   ≥40°C	   and	  severe	   illness	  were	  found	  to	  be	  associated	  with	  the	  HIV	  infection	  and	  could	  reflect	  the	  tendency	  of	  HIV	  infected	  children	  to	  have	  a	  worse	  presentation	  or	  more	  complications	  of	  a	  common	  illness	  compared	  to	  HIV	  negative	  children.	  Abdominal	   tenderness	   was	   also	   found	   to	   be	   significantly	   associated	   with	   the	   HIV	  infection	   and	   could	   be	   explained	   for	   example	   by	   painful	   sensation	   caused	   by	   an	  expansion	  and	  inflammation	  of	  the	  liver	  or	  the	  spleen	  frequent	  in	  HIV-­‐infected	  children.	  It	   could	   be	   as	  well	   due	   to	   an	   underlying	   abdominal	   infectious	   process,	   or	   simply	   to	   a	  more	  severe	  presentation	  of	  the	  disease.	  The	  interesting	  point	  of	  this	  predictor	  is	  that	  it	  is	  an	  easier	  sign	  to	  understand	  and	  assess	  than	  hepato-­‐splenomegaly	  for	  health	  workers	  who	  do	  not	  have	  much	  experience.	  Hepato-­‐splenomegaly	  had	  not	  been	  included	  in	  the	  HIV	   branch	   of	   the	   IMCI	   algorithm	   because	   of	   its	   difficulty	   to	   assess,	   abdominal	  tenderness	   could	   therefore	   be	   a	   good	   alternative	   and	   contribute	   to	   improve	   its	  performance.	  Regarding	   the	   criteria	   included	   in	   the	  HIV	  branch	  of	   IMCI,	  pneumonia,	  oral	   thrush,	  very	   low	  weight	   for	  age	  and	  enlarged	   lymph	  gland	  were	  also	   found	   to	  be	  significantly	  predictive	   of	   HIV	   infection	   in	   the	   present	   study.	   Ear	   discharge	   was	   found	   to	   be	  significant	   but	   was	   not	   included	   in	   the	   analyses	   as	   it	   was	   present	   in	   less	   than	   10	  children.	   Persistent	   diarrhoea,	  which	   generally	   does	   not	   present	  with	   acute	   fever	   and	  parotid	  swelling,	  were	  both	  found	  in	  only	  1	  child	  and	  could	  therefore	  not	  be	  included	  in	  the	  analysis.	   If	   the	  decision	  of	  HIV	   testing	  had	  been	  made	  based	  on	   the	   IMCI	  criteria’s	  used	  in	  Tanzania	  at	  that	  time,	  only	  9	  out	  of	  16	  children	  would	  have	  been	  referred	  to	  a	  VCT	   clinic.	   This	   represents	   only	   56%	   of	   the	   HIV	   positive	   children,	   which	   is	   largely	  insufficient	   taking	   into	   account	   the	  dramatic	   consequences	  of	  not	  being	  diagnosed	   for	  this	  disease.	  If	  only	  one	  criterion	  would	  be	  used	  to	  refer	  the	  child,	  15	  (94%)	  of	  the	  HIV	  positive	  children	  would	  have	  been	  detected,	  but	  with	  a	  quite	  high	  number	  needed	  to	  test	  (27%	  of	  all	  children	  should	  be	  tested).	  In	  a	  country	  with	  high	  HIV	  prevalence	  and	  high	  child	  mortality	  rate,	  a	  highly	  sensitive	  algorithm	  is	  desirable	  for	  early	  identification	  and	  referral	   in	   order	   to	   limit	   disease	   progression	   and	   mortality.	   Nevertheless,	   a	   highly	  specific	   algorithm	   is	   wished	   as	   well	   to	   save	   tests	   in	   settings	   suffering	   of	   constant	  shortage	  of	  tests	  and	  medicines.	  When	  using	  one	  criterion	  as	  cut-­‐off,	  the	  new	  HIV	  clinical	  algorithm	  generated	  in	  this	  study	  improves	  the	  specificity	  of	  the	  algorithm	  while	  keeping	  the	  same	  sensitivity	  when	  compared	  to	  the	  IMCI	  algorithm	  (using	  also	  1	  criteria	  as	  cut-­‐off).	  When	  using	  2	  or	  more	  criteria,	  the	  sensitivity	  improves	  while	  the	  specificity	  remains	  the	  same	  when	  compared	  to	   the	   IMCI	   algorithm	   (using	   also	   2	   criteria	   as	   cut-­‐off)	   .	   WThe	   new	   algorithm	   thus	  enables	  to	  reduce	  the	  number	  of	  children	  needed	  to	  test	  from	  275	  (27%)	  with	  IMCI	  to	  199	   (20%).	  This	  would	  enable	   to	   save	   some	   tests	   in	  periods	  of	   shortage	  by	  providing	  better	   guidance	   to	   clinicians	   on	   which	   febrile	   children	   should	   be	   tested	   in	   priority	  without	  decreasing	  the	  sensitivity	  of	  the	  algorithm.	  This	  new	  algorithm	  is	  not	  aimed	  to	  replace	   the	   IMCI	  HIV	   branch,	   but	  more	   to	   show	   that	   it	   is	   still	   possible	   to	   improve	   by	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introducing	  new	  predictors	  such	  as	  abdominal	  tenderness,	  difficulty	  to	  breath	  or	  chronic	  condition	  for	  example,	  or	  by	  changing	  some	  of	  the	  actual	  criteria.	  	  Furthermore,	   in	  order	  to	  diagnose	  the	  highest	  number	  of	  positive	  children	  it	  would	  be	  better	  to	  only	  use,	  for	  the	  new	  algorithm,	  one	  criterion	  as	  cutoff	  instead	  of	  2.	  It	  would	  increase	  the	  number	  of	  children	  to	  test	  from	  36	  (3.6%)	  to	  199	  (19.8%)	  but	  this	  number	  remains	  reasonable.	  	  The	  clinical	  presentation	  of	  paediatric	  HIV	   infection	   is	  very	  variable	  and	  may	  often	  overlap	  with	  common	  childhood	  illnesses	  symptoms.	  Some	  of	  the	  infected	  children	  will	  develop	  severe	  symptoms	  during	  their	  first	  year	  of	  life	  while	  others	  will	  live	  years	  with	  an	  asymptomatic	  infection.	  Due	  to	  those	  facts,	  the	  use	  of	  a	  clinical	  algorithm	  to	  classify	  weather	  a	  child	  is	  potentially	  infected	  or	  not,	  remains	  risky	  and	  complicated.	  It	  might	  be	  able	  to	  detect	  children	  with	  significant	   immunosuppression	  but	  not	  those	  with	  normal	  or	  close	  to	  normal	  CD4	  counts.	  This	  is	  why	  in	  theory,	  as	  recommended	  in	  the	  Tanzanian	  fourth	  edition	  (April	  2012)	  of	  the	  national	  guidelines	  for	  the	  management	  of	  HIV:	  “Any	  
sick	  child,	  whether	  qualifying	  by	  the	  IMCI	  algorithm	  or	  not,	  should	  be	  offered	  HIV	  testing	  
by	   provider-­‐initiated	   testing	   and	   counselling	   (PITC)	   to	   establish	   the	   infection	   status	   as	  
early	   as	   possible”	   (30).	   However,	   in	   Tanzania	   and	   other	   resource-­‐limited	   countries	  where	  diagnostic	  tools	  may	  not	  always	  be	  widely	  available,	  a	  clinical	  identification	  using	  combinations	   of	   specific	   and	   sensitive	   signs	   and	   symptoms	   is	   crucial	   to	   provide	  guidance	  for	   focused	  HIV	  testing	  and	  further	  referral.	  This	  study	  has	   identified	  several	  predictors,	   some	   already	   described	   in	   other	   studies	   and	   other	   rather	   new.	   Those	  predictors	  could	  serve	  to	  adjust	  actual	  algorithm	  to	  assess	  HIV	  infection.	  
	  
5.	  Limitations	  The	   main	   limitation	   of	   this	   study	   is	   the	   low	   number	   of	   children	   that	   were	   HIV	  infected.	   Indeed,	   the	   presentation	   of	   those	   16	   cases	  may	   not	   be	   representative	   of	   the	  entire	   HIV	   paediatric	   population,	   which	   might	   have	   introduced	   a	   bias,	   and	   some	  interesting	  predictors	  may	  have	  been	  absent	  in	  the	  children	  studied	  because	  too	  rare.	  Another	  limitation	  comes	  from	  the	  fact	  that	  only	  febrile	  children	  presenting	  with	  an	  axillary	   temperature	   ≥	   38°C	  were	   included	   in	   the	   present	   study,	   and	   not	   all	   children	  presenting	  with	  an	  acute	  medical	  problem	  to	  health	  facilities.	  However,	  in	  Tanzania	  80%	  of	  the	  children	  consulting	  in	  medical	  centre	  have	  a	  history	  of	  fever	  (but	  not	  necessarily	  a	  temperature	  above	  38°C)	  (31).	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6.	  Conclusion	  The	  clinical	  presentation	  of	  paediatric	  HIV	  infection	  is	  wide	  and	  various.	  If	  in	  theory	  all	  febrile	  children	  consulting	  health	  facilities	  should	  be	  offered	  HIV	  testing,	  in	  Tanzania	  and	  other	  resource-­‐limited	  settings	  where	  testing	  might	  not	  be	  always	  available,	  the	  use	  of	  a	  clinical	  algorithm	  remains	  important	  to	  enable	  an	  early	  detection	  and	  treatment	  of	  infected	   children.	   This	   study	   has	   identified	   several	   interesting	   predictors	   of	   the	   HIV	  infection	  in	  febrile	  children	  attending	  heath	  facilities	  in	  Tanzania.	  The	  predictors	  found	  in	   the	   present	   study	   and	   by	   other	   studies	   could	   therefore	   assist	   in	   predicting	   HIV	  infection	  among	  children	  attending	  heath	  facilities	  and	  improve	  the	  performance	  of	  the	  actual	   algorithm.	  Considering	   that	   IMCI	  has	   started	   to	  be	  used	   in	  an	  electronic	   format	  running	  on	  mobile	  phones	  and	   tablets	   in	  Tanzania	  and	  Burkina	  Faso,	   a	  more	  complex	  score	  with	   higher	   accuracy,	  which	  would	   be	   calculated	   automatically	   by	   the	  machine,	  could	  be	  afforded.	  This	  would	  be	  a	  simple	  and	  thus	  very	  attractive	  tool	  to	  develop	  in	  the	  near	  future.	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